315 related articles for article (PubMed ID: 23054909)
1. Mycobacterium sulfur metabolism and implications for novel drug targets.
Zeng L; Shi T; Zhao Q; Xie J
Cell Biochem Biophys; 2013 Mar; 65(2):77-83. PubMed ID: 23054909
[TBL] [Abstract][Full Text] [Related]
2. Drug targets in mycobacterial sulfur metabolism.
Bhave DP; Muse WB; Carroll KS
Infect Disord Drug Targets; 2007 Jun; 7(2):140-58. PubMed ID: 17970225
[TBL] [Abstract][Full Text] [Related]
3. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis.
Anishetty S; Pulimi M; Pennathur G
Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791
[TBL] [Abstract][Full Text] [Related]
4. The structure, function, and regulation of Mycobacterium FtsZ.
Hong W; Deng W; Xie J
Cell Biochem Biophys; 2013 Mar; 65(2):97-105. PubMed ID: 22932926
[TBL] [Abstract][Full Text] [Related]
5. Vitamin B6 biosynthesis is essential for survival and virulence of Mycobacterium tuberculosis.
Dick T; Manjunatha U; Kappes B; Gengenbacher M
Mol Microbiol; 2010 Nov; 78(4):980-8. PubMed ID: 20815826
[TBL] [Abstract][Full Text] [Related]
6. Novel targets in M. tuberculosis: search for new drugs.
Lamichhane G
Trends Mol Med; 2011 Jan; 17(1):25-33. PubMed ID: 21071272
[TBL] [Abstract][Full Text] [Related]
7. Structural enzymology of sulphur metabolism in Mycobacterium tuberculosis.
Schnell R; Schneider G
Biochem Biophys Res Commun; 2010 May; 396(1):33-8. PubMed ID: 20494107
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis proteases and implications for new antibiotics against tuberculosis.
Zhao QJ; Xie JP
Crit Rev Eukaryot Gene Expr; 2011; 21(4):347-61. PubMed ID: 22181704
[TBL] [Abstract][Full Text] [Related]
9. New targets and inhibitors of mycobacterial sulfur metabolism.
Paritala H; Carroll KS
Infect Disord Drug Targets; 2013 Apr; 13(2):85-115. PubMed ID: 23808874
[TBL] [Abstract][Full Text] [Related]
10. Genes and regulatory networks involved in persistence of Mycobacterium tuberculosis.
Wang X; Wang H; Xie J
Sci China Life Sci; 2011 Apr; 54(4):300-10. PubMed ID: 21267668
[TBL] [Abstract][Full Text] [Related]
11. The interaction topology of Mycobacterium tuberculosis genes response to capreomycin and novel clues for more drug targets.
Zheng F; Xie J
J Cell Biochem; 2011 Oct; 112(10):2716-20. PubMed ID: 21678479
[TBL] [Abstract][Full Text] [Related]
12. Targeting DNA Repair Systems in Antitubercular Drug Development.
Minias A; Brzostek A; Dziadek J
Curr Med Chem; 2019; 26(8):1494-1505. PubMed ID: 29376490
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis.
Riccardi G; Pasca MR; Chiarelli LR; Manina G; Mattevi A; Binda C
Appl Microbiol Biotechnol; 2013 Oct; 97(20):8841-8. PubMed ID: 24037308
[TBL] [Abstract][Full Text] [Related]
15. New strategies in fighting TB: targeting Mycobacterium tuberculosis-secreted phosphatases MptpA & MptpB.
Silva AP; Tabernero L
Future Med Chem; 2010 Aug; 2(8):1325-37. PubMed ID: 21426021
[TBL] [Abstract][Full Text] [Related]
16. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
[TBL] [Abstract][Full Text] [Related]
17. Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design.
Singh G; Kumar A; Maan P; Kaur J
Curr Drug Targets; 2017 Nov; 18(16):1904-1918. PubMed ID: 28699515
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets.
Hudson SA; McLean KJ; Munro AW; Abell C
Biochem Soc Trans; 2012 Jun; 40(3):573-9. PubMed ID: 22616869
[TBL] [Abstract][Full Text] [Related]
19. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
20. Comparative analyses of the proteins from Mycobacterium tuberculosis and human genomes: Identification of potential tuberculosis drug targets.
Sridhar S; Dash P; Guruprasad K
Gene; 2016 Mar; 579(1):69-74. PubMed ID: 26762852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
